Amoxyclav

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Amoxyclav

Property Description
Active Ingredients Amoxicillin, Clavulanic acid
Primary Forms Tablet, Oral Suspension, Injection
Pharmacological Class Penicillin + beta-Lactamase Inhibitor
General Use Treating Bacterial Infections
Origin Semisynthetic

Defining Co-amoxiclav: A Fixed Combination Antibiotic

Co-amoxiclav, commonly known as Amoxyclav, is a combination prescription antibiotic used for the systemic treatment of bacterial infections. It is officially classified as an antibacterial medicine and belongs to the penicillin class combined with an enzyme inhibitor. This formulation is widely recognized in medical literature for its efficacy against specific bacterial strains.

This drug entity is classified as a semisynthetic pharmaceutical, representing an advancement of the traditional beta-Lactam antibiotic group. By providing two distinct active agents in a fixed combination product, the formula expands the range of pathogens it can successfully address. The overall purpose of the drug is to serve as a reliable agent in the fight against infections caused by susceptible organisms, such as those commonly responsible for respiratory or skin infections.

Amoxicillin and Clavulanic Acid: Understanding the Dual Composition

The medicine is composed of two primary active ingredients: Amoxicillin and Clavulanic acid (supplied as the potassium salt). Amoxicillin is the core component that performs the bactericidal action, meaning it directly destroys bacteria, while Clavulanic acid is an essential protective agent.

This synergistic pairing is the defining feature of Amoxyclav. Amoxicillin, a penicillin derivative, works by disrupting the formation of the bacterial cell wall. Clavulanic acid is a beta-Lactamase inhibitor that neutralizes the specific defensive enzymes produced by some bacteria that would otherwise break down and inactivate the Amoxicillin. The drug is available in several dosage form(s), including oral tablets and suspension (the liquid form often used for pediatric patients), as well as an intravenous form for clinical settings.

Why is This Combination Used? General Therapeutic Purpose

The general therapeutic purpose of Amoxyclav is to overcome microbial resistance, ensuring the antibiotic remains effective against resistant strains, which is essential for successful treatment. This dual action makes the medicine capable of treating a broader spectrum of bacterial infections than Amoxicillin used alone. By disabling the defensive bacterial enzymes, the combination provides a robust strategy to prevent the growth and spread of resilient pathogens.

What side effects are possible with Amoxyclav?

Possible Side Effects and Safety Information

The safety profile for Amoxyclav (amoxicillin/clavulanic acid) is primarily defined by the risks common to penicillin-class antibiotics and specific organ-related events associated with the combination.

Adverse Reactions

The most common adverse reactions reported are gastrointestinal (diarrhea, nausea, vomiting) and mucocutaneous candidiasis. Uncommon effects include dizziness, headache, skin rash, pruritus, and reversible elevations in liver enzymes (AST and ALT).

Serious and Clinically Significant Reactions:

  • Hypersensitivity: Severe, occasionally fatal, hypersensitivity reactions (anaphylaxis, angioedema, DRESS syndrome, Stevens-Johnson syndrome) have been documented. The drug is contraindicated in patients with a history of serious hypersensitivity to any penicillin or other beta-lactam agents.
  • Hepatobiliary: Hepatitis and cholestatic jaundice have been reported, primarily in males and the elderly, and may be associated with prolonged treatment. These events can be severe, and the drug is contraindicated in patients with a prior history of amoxicillin/clavulanic acid-associated hepatic dysfunction.
  • Gastrointestinal: Antibiotic-associated colitis, including Clostridium difficile-associated diarrhea and pseudomembranous colitis, requires immediate evaluation.
  • Nervous System: Convulsions have been reported, mainly in patients with impaired renal function or those receiving high doses.

Safety Considerations

Caution is advised in patients with existing hepatic impairment, with monitoring of liver function recommended. In patients with severe renal impairment, dosage adjustments are necessary. Use should be avoided if infectious mononucleosis is suspected, due to an increased risk of rash. High-dose regimens require maintaining adequate fluid intake and urinary output to reduce the risk of crystalluria.

Overdose and Emergency Response

Overdose and When to Seek Help

Official regulatory documents describe that overdose with amoxyclav is typically associated with gastrointestinal symptoms, or may be asymptomatic. The most commonly reported effects include stomach pain and diarrhea, along with sleepiness (somnolence).

However, more serious risks are explicitly documented, primarily linked to high doses or pre-existing medical conditions:

  • Convulsions: Seizures may occur, particularly in patients with impaired renal function or those who have received very high doses.
  • Crystalluria: Amoxicillin crystalluria, which is the presence of crystals in the urine, has been observed following overdose and can potentially lead to renal failure.

Due to these potential serious effects, any suspected overdose requires medical assessment. For management, official labeling advises that treatment is generally supportive. To reduce the possibility of crystalluria, maintaining adequate fluid intake and urinary output is advisable during high-dose exposure. The drug's components, amoxicillin and clavulanic acid, are known to be removable from circulation by haemodialysis in cases of severe overdose.

Therapeutic Uses of Amoxyclav

What Amoxyclav Treats: Main Uses and Benefits

Managing Acute and Resistant Respiratory Symptoms

Amoxyclav is commonly used to help manage symptoms related to acute bacterial respiratory infections, including community-acquired pneumonia and acute exacerbations of chronic lung conditions. This medication is relevant for managing middle ear, sinus, throat, and lung infections. In situations where resistance is a factor, it helps ease the symptom burden of cough, fever, and breathing difficulties, which supports the patient during difficult episodes and assists with maintaining functional stability.

Treatment for Complex Skin, Tissue, and Wound Infections

This medication is applied in addressing complicated infections of the skin and soft tissue, such as severe cellulitis, and is commonly used for treating infections resulting from traumatic injuries like animal or human bites. When applied in managing these infections, it may assist with reducing the intense local pain, purulence, and swelling. This supports the patient's comfort and is relevant for easing symptomatic discomfort. The combination is additionally used to manage complicated urinary tract infections (UTIs) and serious deep-seated infections, including those affecting the bones and joints.

“The combination is often relevant in clinical settings where the infection is associated with resistance, distinguishing it from agents used for non-resistant pathogens.”

Quick Fact: Relief for Heightened Systemic Symptoms The medicine is applied in addressing conditions marked by increased physiological stress where symptoms like fever and intense localized pain require short-term symptomatic assistance to support day-to-day comfort.

Eligibility and Restrictions for Use

Official Eligibility and Contraindicated Populations

Regulatory documents define strict rules for the use of Amoxyclav based on patient history, age, and underlying health conditions.

Contraindicated Populations

Contraindication Basis Absolute Restriction Statement
Hypersensitivity History Patients with a known allergy to any penicillin, other beta-lactam agents (e.g., cephalosporins), or any ingredient in the formulation.
Hepatic Dysfunction Patients with a history of jaundice or liver dysfunction specifically associated with prior Amoxicillin/Clavulanate use.
Comorbidity Patients with suspected or confirmed infectious mononucleosis.
Metabolic Status Patients with Phenylketonuria (PKU) when using aspartame-containing oral formulations (e.g., chewable tablets).

Conditional and Age-Related Eligibility

Eligibility is typically established for adults and children ge 40 kg with normal organ function. However, specific conditions apply to other groups:

  • Organ Impairment: Use is restricted in patients with severe renal impairment (creatinine clearance le 30 mL/min), mandating official dose adjustment. Use in patients with hepatic impairment requires caution and regular monitoring of liver function.
  • Pediatric Patients: Use is established, but specific adult tablet strengths are not recommended for children le 40 kg. Infants younger than 12 weeks have restricted administration frequency.
  • Pregnancy/Lactation: Amoxyclav is generally categorized as FDA Pregnancy Category B. Use during pregnancy is generally limited to when clearly established as necessary. The medicine is considered compatible with breastfeeding, though caution is advised.

What should I know about interactions with other medicines?

The regulatory profile for Amoxyclav interactions is defined by several documented pharmacokinetic and pharmacodynamic patterns that mandate specific constraints on co-administration. These interactions can modify the plasma concentration of either Amoxyclav or the co-administered drug, or they can alter the patient's physiological risk profile.

Official Interaction Patterns

Interacting Substance Officially Documented Outcome Interaction Type
Probenecid Results in increased and prolonged plasma concentrations of Amoxicillin due to reduced renal tubular secretion. Pharmacokinetic
Oral Anticoagulants (e.g., Warfarin) Associated with abnormal prolongation of prothrombin time (INR), formally documenting an increased risk of bleeding. Pharmacodynamic
Methotrexate Can elevate serum concentrations due to competition for common renal elimination systems. Pharmacokinetic
Allopurinol Increases the incidence of skin rash. Pharmacodynamic
Combined Oral Contraceptives Officially documented potential for reduced efficacy. Exposure-Modifying
Bacteriostatic Antibiotics May interfere with the bactericidal effect of the penicillin component. Pharmacodynamic

Drug-Food Constraint

The official interaction with food mandates administration at the start of a meal. This timing is documented to enhance the absorption of the Clavulanate component. The medicine is formally restricted for use in patients with a history of serious hypersensitivity reactions to beta-lactam drugs or a history of drug-associated cholestatic jaundice.

Mechanism of Action

How Amoxyclav Works

Amoxicillin, a beta-lactam compound, functions as a structural analog of the D-Ala-D-Ala terminus of peptidoglycan precursors. It covalently binds to the active site of Penicillin-Binding Proteins (PBPs), which are transpeptidases essential for bacterial cell wall biosynthesis. This interaction irreversibly inhibits the cross-linking of peptidoglycan chains, leading to a loss of cell wall integrity and subsequent osmotic instability.

Clavulanic acid acts as a suicide inhibitor of beta-lactamase enzymes, which typically hydrolyze and inactivate amoxicillin. Clavulanic acid preferentially binds to the beta-lactamase active site, forming a stable covalent complex that permanently deactivates the enzyme protein. This synergistic action sustains an active concentration of amoxicillin at the bacterial cell membrane, allowing it to proceed with full inhibition of cell wall synthesis, culminating in bacterial cell lysis.

Dosage and Administration Information

How to Use Amoxyclav: Official Administration Guidelines

Amoxyclav (Amoxicillin and Clavulanate Potassium) is administered via the oral route (as tablets, chewable tablets, or reconstituted suspension) and, in clinical settings, through intravenous (IV) injection or infusion. Proper use is defined by standardized instructions regarding dosing, timing, and patient-specific adjustments.

Administration Instructions

Instruction Domain Official Administration Guidance
Timing with Food Oral forms must be taken at the start of a meal to enhance the absorption of the clavulanate component and minimize potential gastrointestinal intolerance.
Dosing Frequency The dose is typically taken either every 12 hours (twice daily) or every 8 hours (three times daily), depending on the specific formulation and dose chosen.
Course Duration Treatment should generally last 7 to 14 days and must not be extended beyond 14 days without a physician's review.
Preparation Oral suspensions require reconstitution with water and vigorous shaking before first use; the bottle must be shaken before each dose. Dispersible tablets should be stirred into a small amount of water before consumption.

Population-Specific Dosing Rules

Prescribing information mandates specific dose adjustments for patients with impaired renal function (kidney impairment). For adult patients with a Creatinine Clearance (CrCl) less than 30 mL/min, the dosage and frequency must be reduced. Specifically, the 875 mg/125 mg dose is not recommended for CrCl le 30 mL/min. Pediatric dosing is determined by the child's body weight (mg/kg/day) and is also based on the amoxicillin component. For older adults, no specific dose adjustment is considered necessary unless renal function is also impaired.

These standardized protocols provide the non-advisory, structured framework for the correct use of the medicine, ensuring consistency in administration.

Recent Clinical Evidence

Research evidence / Overview of Studies for Amoxyclav


Evidence for Use in Acute Respiratory Infections

Research has primarily focused on Randomized Controlled Trials (RCTs) that studied this medicine in conditions characterized by episodic or acute changes, such as acute infections of the sinuses, middle ear, and the lungs (like acute exacerbations of chronic bronchitis). These studies monitored outcomes related to physical discomfort and systemic or functional imbalance, with the central aim of examined measures of clinical resolution versus measures of clinical failure after a defined time interval. Studies exploring these uses included adults, children, and those with underlying chronic lung conditions. Regulatory summaries generally reported the evidence level as High for these research questions. What remains uncertain is the existence of direct comparison research against Amoxicillin alone.

Evidence for Community-Acquired Pneumonia (CAP)

Research related to Community-Acquired Pneumonia (CAP) includes Systematic Reviews and complex Meta-analyses of existing RCTs. Researchers examined outcomes related to systemic imbalance, specifically measuring clinical resolution and the patient’s need for hospitalization. The research level for this indication is typically assessed as Moderate. Comparative evidence is lacking for certain scenarios, as much of the existing data is structured to measure the drug's results against other active treatments rather than against untreated groups.

Evidence for Skin and Soft Tissue Infections

The research exploring this drug in complex infections, such as severe cellulitis or infections following animal and human bites, relies on a combination of Randomized Controlled Trials (RCTs) and Retrospective Observational Studies. Researchers monitored outcomes related to physical discomfort and local inflammatory or irritative states, specifically measuring clinical success (the resolution of local infection signs as defined by the study protocol) and the need for subsequent surgical intervention. The level of evidence for these research questions is often described as High.

Long-Term Evidence and Follow-up Durations

Research exploring short-term symptom changes is primarily focused on acute, episodic changes, meaning the follow-up durations were limited (typically around 7 to 14 days). This structure means that there is limited information for long-term outcomes or the durability of the observed responses. Since the drug was studied for acute illness, long-term effects are not fully established.

Frequently Asked Questions (FAQ)

Common questions about Amoxyclav (FAQ)


Q: Why does Amoxyclav sometimes cause diarrhea?

Diarrhea is reported as one of the most common adverse effects when taking this medicine. This is because, like many antibiotics, Amoxyclav can disrupt the natural balance of beneficial bacteria (microbiome) in the gut while it is fighting the infection.


Q: Why is the full course of Amoxyclav important, even if I feel better?

Regulatory documents emphasize the importance of completing the full prescribed course of therapy. Stopping the medication too soon may decrease the effectiveness of the treatment and is associated with increasing the risk of bacteria developing resistance to the antibiotic.


Q: Is Amoxyclav generally safe for people with liver disease?

Official prescribing information advises that caution is warranted in patients who have existing liver impairment (hepatic impairment). Official product labeling recommends monitoring liver function when the medicine is used in this population.


Q: Can I crush or chew Amoxyclav tablets?

The official product information specifies that dispersible tablets must be stirred into a small amount of water before consumption. Standard tablets are generally intended to be swallowed whole to ensure the active ingredients are released correctly.


Q: Can Amoxyclav be used to treat a viral infection?

No, Amoxyclav is an antibacterial drug specifically indicated to treat infections caused by susceptible bacteria. It is not effective against infections caused by viruses, such as the common cold or the flu.


Q: Is it normal to feel nauseous after taking Amoxyclav?

Nausea is listed as one of the most common adverse reactions reported in official product information. Official product information notes that taking the medicine at the start of a meal is recommended to enhance absorption and may help reduce potential gastrointestinal upset, including nausea.


Q: Can Amoxyclav affect my sleep?

Although not a very common reaction, central nervous system effects such as insomnia (difficulty sleeping) have been reported as uncommon adverse reactions in clinical literature.


Q: What are the most common side effects of Amoxyclav?

According to official regulatory sources, the most common adverse reactions reported are primarily related to the digestive system. These include diarrhea, nausea, and vomiting, along with mucocutaneous candidiasis (yeast infection).


Q: What happens if I miss a dose of Amoxyclav?

Regulatory guidance provides specific instructions for managing a missed dose, typically advising patients to take it as soon as remembered unless it is close to the next scheduled dose. Patients are generally advised against taking a double dose.


Q: Is a metallic taste in the mouth a known side effect of Amoxyclav?

Yes, an altered sense of taste, medically known as taste perversion (dysgeusia), is a documented adverse reaction associated with the use of this medication.


Q: What kind of bacterial infections is Amoxyclav typically used for?

Amoxyclav is indicated for treating a range of bacterial infections. This typically includes infections of the upper and lower respiratory tract (like sinusitis and acute otitis media), skin and soft tissue, and the urinary tract.


Q: Is it true that Amoxyclav can cause kidney problems?

Official prescribing information requires dose adjustments for patients who have existing kidney impairment. Though rare, serious adverse effects like interstitial nephritis and the formation of crystals in the urine (crystalluria) have been reported.


Q: Can Amoxyclav cause headaches?

Official prescribing information lists headache as an uncommon adverse effect. This is one of the many reported side effects that should be monitored.


Q: Are there any long-term side effects associated with Amoxyclav use?

The official research and clinical studies for this medication focus primarily on acute, short-term treatment of infections. As a result, long-term outcomes or effects extending significantly beyond the treatment period are not fully established in the regulatory documentation.


Q: Does Amoxyclav affect the ability to drive or operate machinery?

Central nervous system effects, such as dizziness (uncommon) and convulsions (rare), have been reported. Patients should be aware that the occurrence of these effects may potentially impair their ability to safely perform tasks requiring full concentration.


Q: Is Amoxyclav considered a broad-spectrum antibiotic?

Yes, Amoxyclav is generally considered a broad-spectrum antibiotic. Its formulation combines amoxicillin with a \beta-lactamase inhibitor, which expands its activity against many different types of bacteria that would normally be resistant to amoxicillin alone.


Q: What should I do if my tongue turns black while on Amoxyclav?

A condition known as "black hairy tongue" (lingua villosa nigra), though uncommon, is a reported adverse event associated with the use of the drug. This is usually a temporary and harmless condition that often resolves after the medication is discontinued.


Q: Can Amoxyclav be given through an injection?

Yes, in addition to oral forms like tablets and suspensions, Amoxyclav is also available as an intravenous (IV) injection or infusion. This form is typically reserved for use in hospital or clinical settings.


Q: What are the signs of an allergic reaction to Amoxyclav?

Signs of a serious allergic reaction (hypersensitivity) can include the development of a skin rash or hives, swelling of the face, tongue, or throat, or difficulty breathing. The drug is contraindicated for anyone with a history of penicillin allergy.


Q: Is it normal for my urine to change color while taking Amoxyclav?

Changes to urine color are not a primary listed side effect. However, patients are advised in the product label to maintain adequate fluid intake to reduce the risk of crystalluria (crystals in the urine), which can cause the urine to appear darker or concentrated.


Q: Can Amoxyclav cause anxiety or mood changes?

Central nervous system effects, including feelings of anxiety or confusion, have been documented as adverse reactions associated with this type of medication.


Q: What types of infections is Amoxyclav not effective against?

Amoxyclav is not effective against infections caused by viruses (such as the flu), fungi, or bacteria that have developed resistance mechanisms not blocked by clavulanic acid. It is important that the medicine only be used for appropriate bacterial infections.


Q: Is there a generic version of Amoxyclav available?

Yes, the combination product containing amoxicillin and clavulanic acid has approved generic versions available, according to regulatory drug product listings.


Q: Why do some doctors prescribe Amoxyclav over Amoxicillin?

The drug is typically prescribed when the bacteria causing the infection are known or likely to produce \beta-lactamase enzymes. Clavulanic acid inhibits these enzymes, allowing the amoxicillin to work effectively, giving the combination a broader spectrum of activity than amoxicillin alone.


Q: Can Amoxyclav be used to prevent infections?

Yes, official prescribing information indicates the drug for the prophylaxis (prevention) of certain infections. For example, it can be used to prevent infections like endocarditis in specific, high-risk patients undergoing certain medical procedures.


Q: Is the liquid suspension of Amoxyclav as effective as the tablet form?

Both the liquid suspension and the tablet form are based on the same active ingredients. The different dosage forms are typically prescribed based on the patient's age and weight; for example, young children are preferably treated with the suspension.


Q: What are the signs that Amoxyclav is not working for my infection?

Regulatory guidance suggests seeking medical advice without delay if the symptoms of the infection persist or worsen after starting the medication. This can be a sign that the antibiotic is not effective against the specific pathogen.


Q: Why is Amoxyclav a prescription-only medicine?

As a potent antibiotic used for treating bacterial infections, Amoxyclav is a prescription-only medicine. This is because its appropriate and safe use requires the supervision of a physician to determine the correct diagnosis, manage the risk of severe side effects, and prevent the growth of antibiotic-resistant bacteria.


Q: Is Amoxyclav effective against MRSA?

Official susceptibility data indicates that Amoxyclav is generally not suitable for use when there is a high risk that the pathogen has a resistance mechanism, such as MRSA (methicillin-resistant Staphylococcus aureus), that is not susceptible to clavulanic acid.

How should Amoxyclav be stored and disposed of?

Storage and Disposal of Amoxyclav

Storage of Amoxyclav (amoxicillin and clavulanate potassium) must adhere strictly to regulatory labeling to maintain stability.

Storage Requirements

Product Form Temperature Range Stability/Handling Constraint
Tablets / Dry Powder Controlled room temperature (20 C to 25 C) Protect from moisture; keep in original, tightly closed container.
Reconstituted Suspension Refrigerated (2 C to 8 C) Do not freeze; discard any unused portion after 10 days.

The medicine must be stored out of the sight and reach of children.

Disposal

Unused or expired Amoxyclav should be disposed of through a medicine take-back program. The product must not be poured down a drain or flushed down the toilet unless specific regulatory instructions advise otherwise. Official guidance recommends mixing unused medicine with an undesirable substance and sealing it for disposal in household trash only if a take-back program is unavailable.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Amoxyclav found in:

A-Z Index: